Avadel Pharmaceuticals to Join Russell 3000 Index

Globe NewswireJun 28 04:05

Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $29

Oppenheimer analyst Francois Brisebois maintains $Avadel Pharmaceuticals(AVDL.US)$ with a buy rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate o

Futu NewsJun 17 20:31 · Ratings

Rodman & Renshaw Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $27

Rodman & Renshaw analyst Brandon Folkes initiates coverage on $Avadel Pharmaceuticals(AVDL.US)$ with a buy rating, and sets the target price at $27.According to TipRanks data, the analyst has a succes

Futu NewsJun 12 05:31 · Ratings

Express News | Vir Biotech rose by 19.66%, while novavax rose by 18.07%. Terns Pharmaceuticals, protagonist therapeutics, pacific biosciences of california, adaptive biotechnologies all rose by 16.84-13.27%. Avadel Pharmaceuticals Plc. dropped 3.82% and performed third

BreakingsJun 6 05:06

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European equities traded in the US as American depositary receipts were higher Wednesday morning, rising 0.93% to 1,436.34 on the S&P Europe Select ADR Index. From continental Europe, the gainers were

MT NewswiresJun 5 23:10

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

DUBLIN, May 30, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of

GlobeNewswireMay 30 20:00